T&L Co Ltd
KOSDAQ:340570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
T&L Co Ltd
Cash from Operating Activities
T&L Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cash from Operating Activities
₩46.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Cash from Operating Activities
₩76.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
SD Biosensor Inc
KRX:137310
|
Cash from Operating Activities
₩156.5B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cash from Operating Activities
₩22.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Cash from Operating Activities
-₩92.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Cash from Operating Activities
₩25.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
T&L Co Ltd
Glance View
T&L Co., Ltd. develops medical polymer material products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2020-11-20. The firm's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The firm sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
See Also
What is T&L Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
46.6B
KRW
Based on the financial report for Dec 31, 2024, T&L Co Ltd's Cash from Operating Activities amounts to 46.6B KRW.
What is T&L Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
43%
Over the last year, the Cash from Operating Activities growth was 43%. The average annual Cash from Operating Activities growth rates for T&L Co Ltd have been 35% over the past three years , 43% over the past five years .
